Tag:
dacetuzumab
Latest Headlines
Latest Headlines
Seattle Genetics shares tank after researchers halt cancer trial
Shares of Seattle Genetics ( SGEN ) skidded down 20 percent this morning after the developer announced that it is shelving a Phase IIb trial for its experimental lymphoma drug after a group of
